1. Home
  2. QURE vs ELV Comparison

QURE vs ELV Comparison

Compare QURE & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$25.21

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Elevance Health Inc.

ELV

Elevance Health Inc.

HOLD

Current Price

$345.74

Market Cap

76.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QURE
ELV
Founded
1998
1944
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
76.6B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
QURE
ELV
Price
$25.21
$345.74
Analyst Decision
Strong Buy
Buy
Analyst Count
12
17
Target Price
$58.55
$387.50
AVG Volume (30 Days)
3.0M
1.7M
Earning Date
11-10-2025
01-28-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
N/A
EPS
N/A
24.39
Revenue
$15,751,000.00
$194,820,000,000.00
Revenue This Year
N/A
$13.22
Revenue Next Year
$158.05
$3.49
P/E Ratio
N/A
$14.07
Revenue Growth
N/A
11.96
52 Week Low
$7.76
$273.71
52 Week High
$71.50
$458.75

Technical Indicators

Market Signals
Indicator
QURE
ELV
Relative Strength Index (RSI) 46.34 53.55
Support Level $19.29 $337.54
Resistance Level $25.75 $346.61
Average True Range (ATR) 1.68 9.14
MACD 1.20 -0.53
Stochastic Oscillator 91.33 50.52

Price Performance

Historical Comparison
QURE
ELV

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About ELV Elevance Health Inc.

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Share on Social Networks: